Balyasny Asset Management
QCOR

Balyasny Asset Management’s QUESTCOR PHARMA INC QCOR Stock Holding History

Balyasny Asset Management’s Portfolio QCOR Stock Details QCOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-9,786
Closed -$582K – 814
2013
Q2 		$445K Buy
+9,786
New +$347K 0.01% 518

Other funds holding QCOR

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SAC
Smith Affiliated Capital New York $86.5B AUM 5.91% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Balyasny Asset Management's QCOR Position: Q3 2013 in Review

Balyasny Asset Management sold out of QUESTCOR PHARMA INC (QCOR) in Q3 2013, closing a stake of 9,786 shares — an estimated $582K sold.

Balyasny Asset Management first reported a position in QCOR in Q2 2013 and held it in 1 quarter. The position peaked at $445K in Q2 2013. 284 funds tracked by Wall St. Rank hold QCOR as of Q3 2013.

  • Balyasny Asset Management reported no remaining QUESTCOR PHARMA INC position as of Q3 2013 after selling out during the quarter.
  • Balyasny Asset Management sold 9,786 QUESTCOR PHARMA INC shares in Q3 2013, an estimated $582K.
  • Balyasny Asset Management first reported a position in QUESTCOR PHARMA INC in Q2 2013 and held it in 1 quarter.
  • Balyasny Asset Management's QUESTCOR PHARMA INC position peaked at $445K in Q2 2013.
  • 284 funds tracked by Wall St. Rank held QUESTCOR PHARMA INC as of Q3 2013.

Based on Balyasny Asset Management's 13F filing for Q3 2013, filed 14 Nov 2013.